GlobalData Healthcare

All articles by GlobalData Healthcare

1. Disruption of Clinical Trial Progress in Oncology by the COVID-19 Pandemic

   Country-wide lockdowns as a countermeasure against COVID-19 have severely affected the clinical development of new agents. Pharmaceutical companies and academic…
   Read More…

   9 Apr
2. Sanofi and partners’ success with repurposed antibodies for Covid-19 depend on recruiting less critically ill patients

   Use of repurposed antibodies already approved for other indications to effectively treat Covid-19, like those from Sanofi in partnership with…
   Read More…

   8 Apr
3. Mixed results from recently completed Covid-19 clinical trials

   With the pandemic of Covid-19 affecting the way of life across the globe, companies continue to accelerate the clinical development…
   Read More…

   2 Apr
4. Influenza drug favipiravir is being tested to treat Covid-19

   Treatment options for Covid-19 are urgently needed as the total number of confirmed cases globally rises to 550,000 on Friday…
   Read More…

   30 Mar
5. Amid Covid-19 and trial delays, Apple and J&J’s CV study may hold advantage

   Apple and Johnson & Johnson’s ongoing Heartline Study aims to evaluate changes in stroke risk and atrial fibrillation (AF) detection…
   Read More…

   30 Mar
6. Hydroxychloroquine trial to begin enrolling Covid-19 hospitalised patients next week

   A placebo-controlled, randomised trial evaluating the use of hydroxychloroquine in patients who have tested positive for Covid-19 and are being…
   Read More…

   30 Mar
7. A closer look at the first in human trial for a Covid-19 vaccine

   With the accelerating global burden from the Covid-19 pandemic, researchers are rapidly searching for a viable vaccine to combat the…
   Read More…

   27 Mar
8. Trial delays in the time of Covid-19

   Last week, GlobalData released an Analyst Briefing detailing the increase in overall clinical trial delays due to the global shift…
   Read More…

   25 Mar
9. Covid-19: Experts say clinical trials may be affected from enrolment to data analysis

   The ongoing Covid-19 pandemic is extensively impacting clinical trials irrespective of indication and not just in terms of recruitment and…
   Read More…

   22 Mar
10. The impact of the Covid-19 pandemic on clinical trials

    The Covid-19 pandemic has the potential to disrupt new and ongoing clinical trials of various medical products. To help combat…
    Read More…

    20 Mar